2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Anagrelide retard: new trials by email Literature Review of Anagrelide retard trials Research Report on Anagrelide retard
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anagrelide Retard in Essential Thrombocythemia Anagrelide retard, Thromboreductin - Essential Thrombocythemia | Phase 3 | Completed | AOP Orphan Pharmaceuticals AG | 106 | 2014-02-01 | 2015-07-29 |
| Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia Anagrelide retard, Placebo - Essential Thrombocythaemia | Phase 3 | Completed | AOP Orphan Pharmaceuticals AG | 146 | 2010-12-01 | 2016-05-26 |
Thrombocythemia, Essential (2) · Myeloproliferative Disorders (1)
AOP Orphan Pharmaceuticals AG (2)
Austria (2) · Bulgaria (2) · Lithuania (2) · Poland (2) · Russia (2) · Croatia (1) · Romania (1) · Slovakia (1) · Ukraine (1)
Barbara Grohmann-Izay, MD (1) · Heinz Gisslinger, Prof., MD (1)